Yacktman Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $97.9M | Buy |
334,315
+5,559
| +2% | +$1.83M | 1.31% | 32 |
|
|
2025
Q4 | $115M | Sell |
328,756
-5,617
| -2% | -$1.9M | 1.61% | 27 |
|
|
2025
Q3 | $108M | Sell |
334,373
-6,967
| -2% | -$2.17M | 1.49% | 30 |
|
|
2025
Q2 | $133M | Sell |
341,340
-1,128
| -0.3% | -$454K | 1.78% | 24 |
|
|
2025
Q1 | $149M | Buy |
342,468
+435
| +0.1% | +$175K | 1.96% | 21 |
|
|
2024
Q4 | $126M | Sell |
342,033
-1,105
| -0.3% | -$462K | 1.48% | 29 |
|
|
2024
Q3 | $178M | Sell |
343,138
-28,717
| -8% | -$15.3M | 1.83% | 23 |
|
|
2024
Q2 | $201M | Sell |
371,855
-2,765
| -0.7% | -$1.46M | 1.89% | 20 |
|
|
2024
Q1 | $194M | Sell |
374,620
-11,201
| -3% | -$5.57M | 1.75% | 22 |
|
|
2023
Q4 | $182M | Sell |
385,821
-1,561
| -0.4% | -$722K | 1.69% | 23 |
|
|
2023
Q3 | $169M | Sell |
387,382
-1,369
| -0.4% | -$621K | 1.66% | 24 |
|
|
2023
Q2 | $173M | Buy |
388,751
+1,580
| +0.4% | +$729K | 1.64% | 24 |
|
|
2023
Q1 | $178M | Buy |
387,171
+471
| +0.1% | +$224K | 1.76% | 24 |
|
|
2022
Q4 | $198M | Buy |
386,700
+1,168
| +0.3% | +$593K | 1.98% | 21 |
|
|
2022
Q3 | $175M | Sell |
385,532
-788
| -0.2% | -$377K | 1.91% | 22 |
|
|
2022
Q2 | $186M | Sell |
386,320
-257
| -0.1% | -$127K | 1.93% | 22 |
|
|
2022
Q1 | $190M | Sell |
386,577
-17,937
| -4% | -$8.2M | 1.69% | 25 |
|
|
2021
Q4 | $188M | Buy |
404,514
+2,206
| +0.5% | +$928K | 1.67% | 24 |
|
|
2021
Q3 | $150M | Sell |
402,308
-3,046
| -0.8% | -$1.16M | 1.44% | 27 |
|
|
2021
Q2 | $155M | Sell |
405,354
-1,285
| -0.3% | -$491K | 1.5% | 26 |
|
|
2021
Q1 | $146M | Buy |
406,639
+7,893
| +2% | +$2.54M | 1.53% | 26 |
|
|
2020
Q4 | $128M | Sell |
398,746
-1,048
| -0.3% | -$322K | 1.58% | 23 |
|
|
2020
Q3 | $107M | Buy |
399,794
+15,257
| +4% | +$4.11M | 1.59% | 22 |
|
|
2020
Q2 | $101M | Sell |
384,537
-10,287
| -3% | -$2.74M | 1.61% | 22 |
|
|
2020
Q1 | $89.6M | Sell |
394,824
-243,288
| -38% | -$66.3M | 1.49% | 22 |
|
|
2019
Q4 | $193M | Sell |
638,112
-102,112
| -14% | -$28.1M | 2.44% | 17 |
|
|
2019
Q3 | $178M | Sell |
740,224
-1,109
| -0.1% | -$304K | 2.18% | 16 |
|
|
2019
Q2 | $209M | Sell |
741,333
-4,691
| -0.6% | -$1.28M | 2.51% | 14 |
|
|
2019
Q1 | $214M | Sell |
746,024
-1,813
| -0.2% | -$524K | 2.65% | 13 |
|
|
2018
Q4 | $196M | Sell |
747,837
-71,315
| -9% | -$19.6M | 2.5% | 12 |
|
|
2018
Q3 | $224M | Sell |
819,152
-1,904
| -0.2% | -$494K | 2.69% | 12 |
|
|
2018
Q2 | $195M | Sell |
821,056
-5,617
| -0.7% | -$1.3M | 2.43% | 12 |
|
|
2018
Q1 | $182M | Sell |
826,673
-9,039
| -1% | -$2.12M | 1.87% | 13 |
|
|
2017
Q4 | $188M | Sell |
835,712
-186,791
| -18% | -$39.8M | 1.81% | 14 |
|
|
2017
Q3 | $194M | Sell |
1,022,503
-5,989
| -0.6% | -$1.14M | 1.88% | 14 |
|
|
2017
Q2 | $193M | Sell |
1,028,492
-5,945
| -0.6% | -$1.07M | 1.88% | 14 |
|
|
2017
Q1 | $171M | Sell |
1,034,437
-3,703
| -0.4% | -$589K | 1.6% | 15 |
|
|
2016
Q4 | $149M | Sell |
1,038,140
-17,095
| -2% | -$2.29M | 1.35% | 17 |
|
|
2016
Q3 | $132M | Sell |
1,055,235
-969
| -0.1% | -$125K | 1.15% | 18 |
|
|
2016
Q2 | $139M | Buy |
1,056,204
+815
| +0.1% | +$112K | 1.15% | 18 |
|
|
2016
Q1 | $147M | Buy |
1,055,389
+1,076
| +0.1% | +$144K | 1.14% | 18 |
|
|
2015
Q4 | $147M | Sell |
1,054,313
-26,547
| -2% | -$3.66M | 1.11% | 19 |
|
|
2015
Q3 | $151M | Sell |
1,080,860
-22,160
| -2% | -$3.33M | 0.99% | 21 |
|
|
2015
Q2 | $181M | Sell |
1,103,020
-1,548,640
| -58% | -$247M | 0.97% | 23 |
|
|
2015
Q1 | $409M | Sell |
2,651,660
-468,864
| -15% | -$66.8M | 1.89% | 18 |
|
|
2014
Q4 | $392M | Sell |
3,120,524
-11,454
| -0.4% | -$1.42M | 1.63% | 19 |
|
|
2014
Q3 | $375M | Sell |
3,131,978
-230,626
| -7% | -$26.5M | 1.56% | 20 |
|
|
2014
Q2 | $362M | Sell |
3,362,604
-218,454
| -6% | -$22.5M | 1.47% | 22 |
|
|
2014
Q1 | $356M | Sell |
3,581,058
-26,056
| -0.7% | -$2.36M | 1.49% | 20 |
|
|
2013
Q4 | $333M | Sell |
3,607,114
-11,052
| -0.3% | -$982K | 1.37% | 20 |
|
|
2013
Q3 | $303M | Sell |
3,618,166
-24,648
| -0.7% | -$2.11M | 1.35% | 20 |
|
|
2013
Q2 | $298M | Buy |
+3,642,814
| New | +$273M | 1.41% | 20 |
|
Other funds holding ELV
VCM
VPM
Yacktman Asset Management's ELV Position: Q1 2026 in Review
Yacktman Asset Management increased its Elevance Health (ELV) stake by 1.7% in Q1 2026, buying an estimated $1.83M and bringing the position to 334,315 shares worth $97.9M. The position accounts for 1.31% of the portfolio, ranked #32.
Yacktman Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $409M in Q1 2015. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Yacktman Asset Management held 334,315 shares of Elevance Health worth $97.9M as of Q1 2026.
- Yacktman Asset Management bought 5,559 Elevance Health shares in Q1 2026, an estimated $1.83M.
- Elevance Health made up 1.31% of Yacktman Asset Management's portfolio in Q1 2026, its #32 holding.
- Yacktman Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Yacktman Asset Management's Elevance Health position peaked at $409M in Q1 2015.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Yacktman Asset Management's 13F filing for Q1 2026, filed 1 May 2026.